I have followed the progress of this stock since listing and I am totally convinced that this stock is going to be the next Cohclear. They have got clearance to sell their revolutionary cardiac heart monitor in Asia and Europe. They have already clocked early sales in Asia, today they launched their product in Paris for Europe, they have FDA applications pending in the US and monitors on trial in a number of Australian hospitals. The company has $14 million in the bank and top quality management and marketing teams. This stock is going to very high places, very quick. Watch this space.
UCM Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
